Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Louise, Dorn"'
Autor:
Robert E. Molokie, Donald Lavelle, Mabel Koshy, Linda R. Bressler, Nasrin Talischy, Louise Dorn, Joseph DeSimone
Publikováno v:
Blood. 99:3905-3908
We have previously demonstrated that 5-aza-2'-deoxycytidine (decitabine) augments fetal hemoglobin (HbF) levels in patients with sickle cell anemia (SS) who did not respond to hydroxyurea (HU). The present study was designed to determine the effect o
Publikováno v:
Journal of Pediatric Nursing. 17:18-27
Life expectancy for adolescents with SCD now extends well into adulthood. As a result, adolescents transfer to adult care. Little empirical evidence exists to show how transfer occurs and how well the current practices now work. The aim of this study
Publikováno v:
Annals of Emergency Medicine. 25:224-229
Study objective: To evaluate insurance status and frequency of use of emergency services in adults with sickle cell disease. Design: Retrospective analysis of visits. Setting: Emergency department and outpatient clinics of an urban university hospita
EVALUATION AND MANAGEMENT OF SICKLE CELL DISEASE IN THE EMERGENCY DEPARTMENT (AN 18-YEAR EXPERIENCE)
Autor:
Louise Dorn, Thomas Lebby, Margaret C. Telfert, Jerrold B. Leikin, Nasrin Talischy, Mabel Koshy
Publikováno v:
American Journal of Therapeutics. 1:309-320
Painful episodes are the most frequent complaints of patients with sickle cell disease. The Emergency Department (ED) has provided management for acute events using the usual triage format for emergencies. A prospective study evaluated the role of th
Autor:
Yogen Saunthararajah, Yi Hsiang Chen, Linda R. Bressler, Joseph DeSimone, Cheryl A. Hillery, Robert E. Molokie, Louise Dorn, Don Lavelle, Stefana Gavazova, Ronald Hoffman
Publikováno v:
Blood. 102(12)
Fetal hemoglobin (HbF) decreases polymerization of sickle hemoglobin (HbS) and improves outcomes in sickle cell disease (SSD). Therefore, a therapeutic goal in SSD is pharmacologic reactivation of HbF. Silencing of the γ-globin (HbF) gene is associa
Autor:
Mabel Koshy, Nasrin Talischy, Donald Lavelle, Wendy van Overveld, Robert E. Molokie, Ronald Hoffman, Louise Dorn, Joseph DeSimone, Linda R. Bressler
Publikováno v:
Blood. 96(7)
Augmentation of the fetal hemoglobin (HbF) levels is of therapeutic benefit in patients with sickle cell anemia. Hydroxyurea (HU), by increasing HbF, lowers rates of pain crisis, episodes of acute chest syndrome, and requirements for blood transfusio
Autor:
Mabel Koshy, Louise Dorn
Publikováno v:
Hematology/oncology clinics of North America. 10(6)
Dissemination of information regarding health care by comprehensive sickle cell centers and early identification of patients needing treatment through mandatory newborn screening programs have significantly reduced morbidity and mortality of sickle c
Autor:
Mabel, Koshy, Jerrold, Leikin, Louise, Dorn, Thomas, Lebby, Nasrin, Talischy, Margaret C., Telfert
Publikováno v:
American journal of therapeutics. 1(4)
Painful episodes are the most frequent complaints of patients with sickle cell disease. The Emergency Department (ED) has provided management for acute events using the usual triage format for emergencies. A prospective study evaluated the role of th
Autor:
Santosh L. Saraf, Michael Gowhari, Lani Krauz, Joseph DeSimone, Stephen Vara, Seema Sidhwani, Louise Dorn, Robert E. Molokie, Yogen Saunthararajah, Giovanni Infusino, Mohammed Farooqui
Publikováno v:
Blood. 112:2479-2479
The clinical diagnosis of erythropoietin deficiency is usually prompted by new onset anemia on a background of elevated serum creatinine, and is then confirmed by measurement of serum erythropoietin. In patients with sickle cell anemia (SCA), who are
Autor:
Ida Walters, Mary Baysinger, Ivy Buchanan, Juliette A. Dahl, Louise Dorn, Grace Finigan, Jane Luff, Gloria Moore, Jackie Myrie, Camilla Noel, Rosalyn Semper
Publikováno v:
Nursing Clinics of North America. 18:139-141